Liminal Biosciences Inc (NASDAQ:LMNL)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - LMNL

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - LMNL

  • Market Cap$120.970m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCA53272L1031

Company Profile

Liminal Biosciences Inc engages in clinical-stage research and commercialization of fibrosis treatments. The company operates in two segments: Small molecule therapeutics and Plasma-derived therapeutics. The Small molecule segment develops and commercializes treatments for lung, liver, and kidney conditions. The Plasma-derived segment sells proteins and specialty plasma in addition to developing a plasma treatment product. Liminal Biosciences does business in Canada, the U.K., and the U.S., and nearly all of its revenue comes from the plasma-derived therapeutics segment.Prometic Life Sciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its own orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs.

Latest LMNL news

Currently there for this company. Visit our news hub for other news .